Surface Plasmon Resonance (SPR) is now the gold standard technique for affinity determination of small and large molecules.
SPR is a label-free method capable of measuring real-time quantitative binding affinities, kinetics and thermodynamic parameters of interacting molecules.
SPR fulfils the requirements of regulatory authorities (FDA, EMA, ICH) for therapeutic antibody approval
Service dedicated for comparability studies of biosimilars and other therapeutic molecules :
Binding to the recombinant target.
Binding to Fcγ receptors (FcγRI, FcγRII, FcγRIII) and neonatal Fc receptor.